NATIONAL HEALTHCARE CORP·4

Mar 6, 4:26 PM ET

McCreary Josh A 4

4 · NATIONAL HEALTHCARE CORP · Filed Mar 6, 2026

Research Summary

AI-generated summary of this filing

Updated

National Healthcare (NHC) SVP/GC Josh McCreary Exercises Options

What Happened
Josh A. McCreary, Senior Vice President & General Counsel of National Healthcare Corp (NHC), exercised 4,500 stock options on 2026-03-04. The exercise reflected an aggregate exercise price of $407,790 (4,500 shares × $90.62). To cover the exercise price and withholding taxes, the company withheld 3,202 shares (valued at $172.83 each, total ~$553,402). Net result: McCreary received 1,298 shares (4,500 − 3,202). The option awards were converted/terminated as part of the exercise.

Key Details

  • Transaction date: March 4, 2026; Form filed March 6, 2026 (appears timely).
  • Exercise: 4,500 options exercised at $90.62 per share → $407,790 total (code M).
  • Withholding/tax payment: 3,202 shares withheld at $172.83 per share → ~$553,402 (code F).
  • Net shares received: 1,298 shares retained by McCreary.
  • Footnotes: Options granted under the 2020 Omnibus Equity Incentive Plan (grant date Feb 24, 2025); grant and exercise exempt from Section 16(b) per Rule 16b‑3(d) (F1). Shares were withheld to cover exercise price and withholding tax obligations (F2).
  • Shares owned after transaction: not provided in the excerpt (see footnote F3 in filing).

Context

  • This was an option exercise with a cashless/stock‑withholding settlement: options converted to shares, and the company withheld a portion to pay exercise costs and taxes. The derivative (option) positions were therefore terminated as part of the exercise.
  • Such exercises are routine for executives exercising vested awards; the net increase in beneficial holdings here is 1,298 shares.

Insider Transaction Report

Form 4
Period: 2026-03-04
McCreary Josh A
Senior VP & General Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-03-04$90.62/sh+4,500$407,79015,900 total
  • Tax Payment

    Common Stock

    [F2][F3]
    2026-03-04$172.83/sh3,202$553,40212,698 total
  • Exercise/Conversion

    Option to Purchase Common Stock

    [F1]
    2026-03-044,5009,000 total
    Exercise: $90.62From: 2026-02-24Exp: 2030-02-24Common Stock (13,500 underlying)
Holdings
  • Option to Purchase Common Stock

    Exercise: $53.94From: 2024-03-08Exp: 2028-03-08Common Stock (4,000 underlying)
    4,000
  • Option to Purchase Common Stock

    Exercise: $94.10From: 2025-03-05Exp: 2029-03-05Common Stock (8,000 underlying)
    8,000
  • Option to Purchase Common Stock

    Exercise: $157.13From: 2027-02-23Exp: 2031-02-23Common Stock (14,000 underlying)
    14,000
Footnotes (3)
  • [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
  • [F2]Shares were withheld by the Company to pay the exercise price and withholding tax obligations.
  • [F3]Total amount of shares beneficially owned following transactions reported on this form.
Signature
/s/ Josh McCreary|2026-03-06

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4